Department of Urology, The People's Hospital of Longhua, The Affiliated Hospital of Southern Medical University, Shenzhen, China.
The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Clin Exp Med. 2023 Nov;23(7):3549-3564. doi: 10.1007/s10238-023-01089-y. Epub 2023 Jul 3.
BACKGROUND: Many studies have shown an association between COVID-19 and autoimmune diseases (ADs). Studies on COVID-19 and ADs have also increased significantly, but there is no bibliometric analysis to summarize the association between COVID-19 and ADs. The purpose of this study was to perform a bibliometric and visual analysis of published studies related to COVID-19 and ADs. METHODS: Based on the Web of Science Core Collection SCI-Expanded database, we utilize Excel 2019 and visualization analysis tools Co-Occurrence13.2 (COOC13.2), VOSviewer, CiteSpace, and HistCite for analysis. RESULTS: A total of 1736 related kinds of papers were included, and the number of papers presented an overall increasing trend. The country/region with the most publications is the USA, the institution is the Harvard Medical School, the author is Yehuda Shoenfeld from Israel, and the journal is Frontiers in Immunology. Research hotspots include immune responses (such as cytokines storm), multisystem ADs (such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis), treatment modalities (such as hydroxychloroquine, rituximab), vaccination and autoimmune mechanisms (such as autoantibodies, molecular mimicry). The future research direction may be the mechanisms and treatment ideas of the association between ADs and COVID-19 (such as NF-κB, hyperinflammation, antiphospholipid antibodies, neutrophil extracellular traps, granulocyte-macrophage colony-stimulating factor), other cross-diseases of COVID-19 and ADs (such as inflammatory bowel disease, chronic mucocutaneous candidiasis, acute respiratory distress syndrome). CONCLUSION: The growth rate of publications regarding ADs and COVID-19 has risen sharply. Our research results can help researchers grasp the current status of ADs and COVID-19 research and find new research directions in the future.
背景:许多研究表明 COVID-19 与自身免疫性疾病(AD)之间存在关联。针对 COVID-19 和 AD 的研究也显著增加,但目前尚无文献计量分析来总结 COVID-19 与 AD 之间的关联。本研究旨在对与 COVID-19 和 AD 相关的已发表研究进行文献计量和可视化分析。
方法:基于 Web of Science 核心合集 SCI-Expanded 数据库,我们使用 Excel 2019 和可视化分析工具 Co-Occurrence13.2(COOC13.2)、VOSviewer、CiteSpace 和 HistCite 进行分析。
结果:共纳入 1736 种相关文献,文献数量呈总体增长趋势。发文量最多的国家/地区是美国,发文机构是哈佛医学院,发文作者是来自以色列的 Yehuda Shoenfeld,发文期刊是 Frontiers in Immunology。研究热点包括免疫反应(如细胞因子风暴)、多系统 AD(如系统性红斑狼疮、类风湿关节炎和多发性硬化症)、治疗方式(如羟氯喹、利妥昔单抗)、疫苗接种和自身免疫机制(如自身抗体、分子模拟)。未来的研究方向可能是 AD 与 COVID-19 关联的机制和治疗思路(如 NF-κB、过度炎症、抗磷脂抗体、中性粒细胞胞外陷阱、粒细胞-巨噬细胞集落刺激因子)、COVID-19 与 AD 的其他交叉疾病(如炎症性肠病、慢性黏膜皮肤念珠菌病、急性呼吸窘迫综合征)。
结论:AD 与 COVID-19 相关研究的文献增长率大幅上升。我们的研究结果可以帮助研究人员掌握 AD 与 COVID-19 研究的现状,并在未来找到新的研究方向。
Medicine (Baltimore). 2023-5-26
Immunoinformatics (Amst). 2025-6
Discov Oncol. 2025-4-15
Front Pharmacol. 2023-3-3
Viruses. 2023-1-18
Curr Opin Allergy Clin Immunol. 2023-4-1